A total of 140 patients were studied under controlled trial, all suffering from CLL (chronic lymphocytic leukemia) and CML (chronic myeloid leukemia). 60 of these patients suffered from CLL (Group A) and 80 patients suffered from CML (Group B). All of these patients were transfused with Lymphocyte specific killer stem cells which were modified from hemopoeitic stem cells of umbilical cord. As post stem cell booster Imatinib 400 mg od plus Pazopanib 400 mg od combination was used in Group A and in Group B as post stem cell boosters. Blood Complete Picture done at 10 days post stem cell showed marked improvement in lymphocyte count in both groups. By the end of 1 month hemoglobin and platelets both started improving also. By end of 2 months the blood complete picture showed normal studies as per hemoglobin, platelets and lymphocyte counts. The treatment continued for 6 months and all these patients were declared cancer free.
Lymphocyte specific killer stem cells modified from pleuripotent hemopoeitic umbilical cord stem cells are curative for treatment of all kinds of leukemias. Imatinib and Pazopanib are potent post stem cell boosters in leukemias.